Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Screening for inhibitors of microglia to reduce neuroinflammation.
Elevated and dysregulated bone morphogenic proteins in immune cells of patients with relapsing-remitting multiple sclerosis.
Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients.
Growth Hormone and Disease Severity in Early Stage of Multiple Sclerosis.
Factors Associated with Employment Status in Individuals with Multiple Sclerosis.
Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy.
Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cells.
Cannabinoids: Medical implications.
Internal jugular vein blood flow in multiple sclerosis patients and matched controls.
Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis.
Impact of a 5-day expedition to machu picchu on persons with multiple sclerosis.
Neurologic disease with pregnancy and considerations for the obstetric anesthesiologist.
Comment on: Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
Poster Abstracts from the Fourth International Symposium on Gait and Balance in Multiple Sclerosis: The Role of CognitionCleveland Clinic • Cleveland, Ohio, USA • October 10 & 11, 2014.
Dynamics and Mechanisms of CNS Myelination.
Urodynamic changes in mice with experimental autoimmune encephalomyelitis correlate with neurological impairment.
Pharmacological treatments for fatigue associated with palliative care.
Incidence of Multiple Sclerosis and Related Disorders in Asian Populations of British Columbia.
Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta.
Late-onset Multiple Sclerosis in Isfahan, Iran.
Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study.
Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosis.
Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?
[Relationship between biochemical parameters of cerebrospinal fluid and the course of multiple sclerosis.]
[The latest advance of correlation between autophagy and optic neuritis].
Pages
« first
‹ previous
…
512
513
514
515
516
517
518
519
520
…
next ›
last »